| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
159,210,000 |
| Market
Cap: |
1.10(B) |
| Last
Volume: |
2,204,422 |
Avg
Vol: |
2,198,459 |
| 52
Week Range: |
$2.7 - $7.11 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drugs - Generic |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Amneal Pharmaceuticals is a holding company. Through its subsidiaries, Co. is a pharmaceutical company engaging in developing, manufacturing, marketing and distributing generic and branded pharmaceutical products across an array of dosage forms and therapeutic areas. Co. has three reportable segments: Generics, which includes various product families covering a range of dosage forms and delivery systems; Specialty, which is engaged in the development, promotion, sale and distribution of proprietary branded pharmaceutical products, with a focus on products addressing central nervous system disorders; and AvKARE, which provides pharmaceuticals, medical and surgical products, and services.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-03-17 |
2023-12-15 |
2023-06-16 |
2022-06-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Burr Robert L |
Director |
– • – |
2010-12-02 |
4 |
OE |
$7.10 |
$73,630 |
D/D |
9,500 |
53,650 |
|
- |
|
| Benet Leslie Z |
Director |
– • – |
2010-12-01 |
4 |
S |
$18.10 |
$181,000 |
D/D |
(10,000) |
7,000 |
|
- |
|
| Benet Leslie Z |
Director |
– • – |
2010-12-01 |
4 |
OE |
$6.55 |
$97,500 |
D/D |
14,000 |
17,000 |
|
- |
|
| Hsu Larry |
President and CEO |
• • – |
2010-11-15 |
4 |
D |
$18.97 |
$10,434 |
I/I |
(550) |
41,544 |
|
- |
|
| Mengler Christopher |
Former Division President |
– – – |
2010-11-05 |
4 |
S |
$19.32 |
$144,127 |
D/D |
(7,460) |
0 |
|
- |
|
| Hsu Larry |
President and CEO |
• • – |
2010-10-29 |
4 |
A |
$0.00 |
$0 |
I/I |
19,435 |
42,094 |
|
- |
|
| Hsu Larry |
President and CEO |
• • – |
2010-10-26 |
4 |
D |
$21.48 |
$17,678 |
I/I |
(823) |
22,659 |
|
- |
|
| Mengler Christopher |
Former Division President |
– – – |
2010-10-25 |
4 |
S |
$21.24 |
$869,905 |
D/D |
(40,956) |
7,460 |
|
- |
|
| Mengler Christopher |
Former Division President |
– – – |
2010-10-22 |
4 |
S |
$21.26 |
$42,520 |
D/D |
(2,000) |
29,666 |
|
- |
|
| Hsu Larry |
President and CEO |
• • – |
2010-10-11 |
4 |
D |
$21.45 |
$19,434 |
I/I |
(906) |
23,482 |
|
- |
|
| Nestor Michael |
President, Impax Pharm. Div. |
• – – |
2010-08-13 |
4 |
B |
$16.06 |
$26,419 |
I/I |
1,645 |
3,645 |
1.99 |
- |
|
| Chao Allen |
Director |
– • – |
2010-08-13 |
4 |
B |
$16.03 |
$740,586 |
I/I |
46,200 |
20,000 |
2.1 |
- |
|
| Chao Allen |
Director |
– • – |
2010-08-12 |
4 |
B |
$15.72 |
$216,936 |
I/I |
13,800 |
180,000 |
2.1 |
- |
|
| Mengler Christopher |
President, Global Pharm. Div. |
• – – |
2010-08-12 |
4 |
B |
$15.19 |
$30,380 |
D/D |
2,000 |
59,706 |
2.74 |
- |
|
| Hsu Larry |
President and CEO |
• • – |
2010-08-12 |
4 |
B |
$15.40 |
$77,000 |
I/I |
5,000 |
2,369,568 |
2.66 |
- |
|
| Hsu Larry |
President and CEO |
• • – |
2010-08-11 |
4 |
B |
$16.03 |
$160,300 |
I/I |
10,000 |
2,364,568 |
2.66 |
- |
|
| Fleming Nigel |
Director |
– • – |
2010-08-10 |
4 |
S |
$16.83 |
$126,225 |
D/D |
(7,500) |
26,640 |
|
- |
|
| Fleming Nigel |
Director |
– • – |
2010-08-10 |
4 |
OE |
$7.10 |
$53,250 |
D/D |
7,500 |
34,140 |
|
- |
|
| Hsu Larry |
President and CEO |
• • – |
2010-08-03 |
4 |
OE |
$5.00 |
$250,000 |
D/D |
50,000 |
390,793 |
|
- |
|
| Nestor Michael |
President, Impax Pharm. Div. |
• – – |
2010-06-07 |
4 |
D |
$20.37 |
$56,038 |
D/D |
(2,751) |
51,950 |
|
- |
|
| Fleming Nigel |
Director |
– • – |
2010-06-04 |
4 |
S |
$20.37 |
$27,703 |
D/D |
(1,360) |
26,640 |
|
- |
|
| Terreri Peter R |
Director |
– • – |
2010-06-04 |
4 |
S |
$20.51 |
$30,047 |
D/D |
(1,465) |
14,535 |
|
- |
|
| Burr Robert L |
Director |
– • – |
2010-06-04 |
4 |
S |
$20.32 |
$20,320 |
D/D |
(1,000) |
44,150 |
|
- |
|
| Terreri Peter R |
Director |
– • – |
2010-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
4,000 |
16,000 |
|
- |
|
| Nestor Michael |
President, Impax Pharm. Div. |
• – – |
2010-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
13,000 |
54,701 |
|
- |
|
531 Records found
|
|
Page 16 of 22 |
|
|
0.11 (1.57%) 
